LBP AM’s Amgen AMGN Stock Holding History

LBP AM’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.81M	Sell	10,820 -40,956	-79%	-$14.6M	0.05%	229
2025 Q4	$16.9M	Buy	51,776 +26,897	+108%	+$8.53M	0.2%	103
2025 Q3	$7.02M	Buy	24,879 +542	+2%	+$157K	0.09%	190
2025 Q2	$6.8M	Sell	24,337 -13,143	-35%	-$3.72M	0.1%	173
2025 Q1	$11.7M	Sell	37,480 -1,507	-4%	-$445K	0.18%	113
2024 Q4	$10.2M	Sell	38,987 -16,944	-30%	-$5.03M	0.14%	136
2024 Q3	$18M	Sell	55,931 -3,046	-5%	-$996K	0.27%	78
2024 Q2	$18.4M	Sell	58,977 -1,092	-2%	-$321K	0.76%	26
2024 Q1	$17.1M	Sell	60,069 -947	-2%	-$277K	0.68%	35
2023 Q4	$17.6M	Buy	61,016 +2,632	+5%	+$717K	0.39%	69
2023 Q3	$15.7M	Buy	58,384 +20,847	+56%	+$5.2M	0.35%	78
2023 Q2	$8.33M	Buy	37,537 +5,916	+19%	+$1.37M	0.2%	115
2023 Q1	$7.64M	Sell	31,621 -1,467	-4%	-$360K	0.19%	109
2022 Q4	$8.69M	Buy	+33,088	New	+$8.87M	0.25%	88

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

LBP AM's AMGN Position: Q1 2026 in Review

LBP AM reduced its Amgen (AMGN) stake by 79% in Q1 2026, selling an estimated $14.6M and leaving 10,820 shares worth $3.81M. The position accounts for 0.05% of the portfolio, ranked #229.

LBP AM first reported a position in AMGN in Q4 2022 and has held it in 14 quarters since. The position peaked at $18.4M in Q2 2024. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

LBP AM held 10,820 shares of Amgen worth $3.81M as of Q1 2026.
LBP AM sold 40,956 Amgen shares in Q1 2026, an estimated $14.6M.
Amgen made up 0.05% of LBP AM's portfolio in Q1 2026, its #229 holding.
LBP AM first reported a position in Amgen in Q4 2022 and has held it in 14 quarters since.
LBP AM's Amgen position peaked at $18.4M in Q2 2024.
3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on LBP AM's 13F filing for Q1 2026, filed 27 Apr 2026.